CTC Bio Inc
KOSDAQ:060590
Intrinsic Value
CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. [ Read More ]
The intrinsic value of one CTC Bio Inc stock under the Base Case scenario is 3 908.28 KRW. Compared to the current market price of 7 950 KRW, CTC Bio Inc is Overvalued by 51%.
Valuation Backtest
CTC Bio Inc
Run backtest to discover the historical profit from buying and selling CTC Bio Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Balance Sheet Decomposition
CTC Bio Inc
Current Assets | 80.5B |
Cash & Short-Term Investments | 21.3B |
Receivables | 25B |
Other Current Assets | 34.2B |
Non-Current Assets | 82.1B |
Long-Term Investments | 1.1B |
PP&E | 61.9B |
Intangibles | 11.2B |
Other Non-Current Assets | 7.9B |
Current Liabilities | 70.9B |
Accounts Payable | 6B |
Accrued Liabilities | 14.6B |
Short-Term Debt | 29.9B |
Other Current Liabilities | 20.5B |
Non-Current Liabilities | 16.4B |
Long-Term Debt | 3.7B |
Other Non-Current Liabilities | 12.7B |
Earnings Waterfall
CTC Bio Inc
Revenue
|
135.8B
KRW
|
Cost of Revenue
|
-90.6B
KRW
|
Gross Profit
|
45.2B
KRW
|
Operating Expenses
|
-50.3B
KRW
|
Operating Income
|
-5.1B
KRW
|
Other Expenses
|
-9.1B
KRW
|
Net Income
|
-14.2B
KRW
|
Free Cash Flow Analysis
CTC Bio Inc
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
CTC Bio Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
CTC Bio Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
CTC Bio Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
CTC Bio Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
CTC Bio Inc
According to Wall Street analysts, the average 1-year price target for CTC Bio Inc is 25 000 KRW .
Shareholder Return
Price
CTC Bio Inc
Average Annual Return | -1.8% |
Standard Deviation of Annual Returns | 26.77% |
Max Drawdown | -54% |
Market Capitalization | 190.1B KRW |
Shares Outstanding | 23 908 755 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. The company is headquartered in Hongcheon, Gangwon-Do. The company went IPO on 2002-02-21. The company pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. The company also involves in the development of pharmaceutical manufacturing technology and know-how. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one CTC Bio Inc stock under the Base Case scenario is 3 908.28 KRW.
Compared to the current market price of 7 950 KRW, CTC Bio Inc is Overvalued by 51%.